- Report
- March 2025
- 132 Pages
Global
From €3327EUR$3,500USD£2,795GBP
- Report
- March 2025
- 231 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2023
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
Asia Pacific
From €1711EUR$1,800USD£1,438GBP
- Report
- February 2023
- 266 Pages
Global
From €3993EUR$4,200USD£3,354GBP
- Report
- December 2023
- 221 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- August 2024
- 100 Pages
Global
From €3500EUR$3,944USD£3,043GBP
The HIV Rapid Test Kits market is a subset of the Point-of-Care Diagnostics market, which focuses on providing medical tests that can be performed quickly and conveniently outside of a laboratory setting. HIV Rapid Test Kits are designed to detect the presence of HIV antibodies in a patient's blood sample, allowing for a quick diagnosis of HIV infection. These kits are typically used in settings such as hospitals, clinics, and community health centers, and are often used in conjunction with other diagnostic tests. The HIV Rapid Test Kits market is driven by the need for rapid diagnosis of HIV infection, as well as the increasing availability of these kits in low- and middle-income countries.
Some companies in the HIV Rapid Test Kits market include Abbott, Alere, Bio-Rad, Becton Dickinson, Cepheid, and Roche. Show Less Read more